- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.
Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
Bora Pharmaceuticals Fuels Global Expansion with Acquisition in US
January 17th 2024
The acquisition marks a pivotal expansion for the company into the US market.
Merck to Acquire Harpoon Therapeutics in Deal Valued at $680 Million
January 16th 2024
Through the acquisition of Harpoon Therapeutics, Merck will gain an investigational delta-like ligand 3-targeting T-cell engager under development for cancer treatment.
AI Biotech Secures Funding to Speed Up Stem Cell Therapy Development
January 16th 2024
CellVoyant has raised £7.6 million in seed funding to speed up the development of novel cell therapies.
Pluri Launches New Cell Therapy CDMO Division
January 11th 2024
Pluri has launched PluriCDMO, a new contract development and manufacturing organization business that will offer cell therapy manufacturing services.
Clarivate Highlights 13 Potential Drugs to Watch in Latest Report
January 10th 2024
Clarivate's Drugs to Watch report highlights 13 potential blockbuster drugs and gamechangers set to launch in 2024.
Cherwell Joins AnalytiChem Group
January 10th 2024
Cherwell Laboratories’ cleanroom microbiology solutions will join AnalytiChem’s group of seven companies across Europe, North America, and Australia.
GSK to Acquire Aiolos Bio, Expands Respiratory Portfolio
January 9th 2024
In a deal worth up to $1.4 billion, GSK aims to acquire Aiolos Bio and gain an expanded pipeline of biologic-based respiratory therapeutic candidates.
WuXi AppTec Expands Peptide and API Manufacturing
January 9th 2024
The expansion will boost solid-phase peptide synthesis total reactor volume to 32,000 L.
Boehringer Ingelheim and Ribo Partner on RNA-based Liver Disease Therapeutics
January 5th 2024
Under the collaboration, Boehringer Ingelheim and Ribo will develop RNA-based therapeutics to treat NASH/MASH.
Roche to Acquire Point-of-Care Technology from LumiraDx in $350 Million Deal
January 4th 2024
Roche will acquire select parts of the LumiraDx group related to that company’s point-of-care technology, which integrates multiple tests on a single instrument.